Affiliation:
1. Division of Renal Diseases and Hypertension, Department of Medicine, University of Colorado Denver, and Veterans Affairs Medical Center, Aurora, Colorado
Abstract
Hyperphosphatemia associated with chronic kidney disease is one of the factors that can promote vascular calcification, and intestinal Pi absorption is one of the pharmacological targets that prevents it. The type II Na-Pi cotransporter NaPi-2b is the major transporter that mediates Pi reabsorption in the intestine. The potential role and regulation of other Na-Pi transporters remain unknown. We have identified expression of the type III Na-Pi cotransporter PiT-1 in the apical membrane of enterocytes. Na-Pi transport activity and NaPi-2b and PiT-1 proteins are mostly expressed in the duodenum and jejunum of rat small intestine; their expression is negligible in the ileum. In response to a chronic low-Pi diet, there is an adaptive response restricted to the jejunum, with increased brush border membrane (BBM) Na-Pi transport activity and NaPi-2b, but not PiT-1, protein and mRNA abundance. However, in rats acutely switched from a low- to a high-Pi diet, there is an increase in BBM Na-Pi transport activity in the duodenum that is associated with an increase in BBM NaPi-2b protein abundance. Acute adaptive upregulation is restricted to the duodenum and induces an increase in serum Pi that produces a transient postprandial hyperphosphatemia. Our study, therefore, indicates that Na-Pi transport activity and NaPi-2b protein expression are differentially regulated in the duodenum vs. the jejunum and that postprandial upregulation of NaPi-2b could be a potential target for treatment of hyperphosphatemia.
Publisher
American Physiological Society
Cited by
133 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献